News
Isis Pharmaceuticals' New Cholesterol Drug Might Be a Hit, But It Won't Be Soon BNET Pharma
View ArticleNews
Genzyme's Mipomersen: Liver Side Effects Could Limit a Promising Cholesterol Drug BNET Pharma
View ArticleNews
Awash in cash and possibilities, Isis Pharmaceuticals forges ahead North Country Times, CA
View ArticleNews
Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air Seeking Alpha
View ArticleGenzyme, Isis Say Mipomersen Cut LDL-C in Two Studies
Genzyme, Isis Say Mipomersen Cut LDL-C in Two Studies Bloomberg
View ArticleGenzyme and Isis submit European MAA for mipomersen
Genzyme and Isis submit European MAA for mipomersen Pharmabiz
View ArticleNovel Lipid Management Therapies In High-Risk Patients - A Paradigm Shift
Novel Lipid Management Therapies In High-Risk Patients - A Paradigm Shift Seeking Alpha
View Article3 Biotechs Facing the Firing Squad Next Week
3 Biotechs Facing the Firing Squad Next Week Motley Fool
View ArticleAegerion Vs. Isis: Which One Is The Buy?
Aegerion Vs. Isis: Which One Is The Buy? Seeking Alpha
View ArticleIsis Falls on Concerns Over Abnormal Growths With Kynamro
Isis Falls on Concerns Over Abnormal Growths With Kynamro Bloomberg
View ArticleIsis Pharma/Genzyme FDA Panel Live Blog
Isis Pharma/Genzyme FDA Panel Live Blog TheStreet.com
View ArticleFDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Comment...
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Forbes
View Article
